Advisers want 'greater personalisation' of protection products

clock • 1 min read

Advisers have identified medical conditions such as diabetes and high blood pressure and key lifestyle changes as the areas where they would like to see personalised protection products, Ipipeline has found.

When asked if they would like to see ‘Personalised products for common conditions such as diabetes, cholesterol, blood pressure etc', 90% of advisers surveyed said ‘yes'. Meanwhile, 67% would like to see ‘Personalised products for different customer segments e.g. self-employed, renters, new parents'. The most important type of product that advisers would like to see is something that offers ‘Flexibility throughout the policy to meet customers' evolving needs' (89%) while products tailored for new parents came second (86%). Other areas for possible development centred around work an...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

AFM members pay out £70m on IP claims in 2023

AFM members pay out £70m on IP claims in 2023

Claims for musculoskeletal continue to rise

Jaskeet Briah
clock 17 April 2024 • 2 min read
Claims pay outs rise 25% for Reassured's customers

Claims pay outs rise 25% for Reassured's customers

MetLife paid out to 692 customers

Jaskeet Briah
clock 17 April 2024 • 1 min read
Guardian joins Mortgage Advice Bureau's protection panel

Guardian joins Mortgage Advice Bureau's protection panel

"This partnership will add more value to the advice and products we offer"

Jaskeet Briah
clock 17 April 2024 • 1 min read